What is Extracorporeal membrane oxygenation ECMO system: Uses, Safety, Operation, and top Manufacturers!

Introduction

Extracorporeal membrane oxygenation ECMO system is a high-acuity life-support medical device designed to temporarily support gas exchange (oxygenation and carbon dioxide removal) and, in some configurations, circulatory support by pumping blood through an external circuit and membrane oxygenator.

In practical terms, ECMO sits on the same “family tree” as cardiopulmonary bypass (used in the operating room) but is engineered and governed differently: ECMO is typically used for longer durations, in the ICU environment, and with a strong emphasis on continuous bedside monitoring, standardized checklists, and closed-loop communication. Many programs also consider ECMO part of a broader extracorporeal life support (ECLS) capability that may interact with other extracorporeal therapies (such as continuous renal replacement therapy) depending on local policy and equipment compatibility.

In modern hospitals, this hospital equipment matters because it can bridge critically ill patients through potentially reversible respiratory and/or cardiac failure, support complex procedures, and enable inter-facility transport when conventional therapies are insufficient. It is also one of the most operationally demanding categories of clinical device: it requires specialized staff, robust infrastructure, strict infection control, disciplined alarm response, and dependable vendor support for both capital equipment and single-use disposables.

From a hospital operations perspective, ECMO is also a “systems commitment” rather than a single procurement decision. Beyond the bedside, it impacts ICU bed planning, blood bank utilization, lab turnaround times, biomedical engineering workload, and training schedules. Many organizations formalize this by creating an ECMO steering committee or governance group that defines who can start ECMO, how to document events, and how to manage scarce resources during surges.

This article is informational and operationally focused—not medical advice. It is written for hospital administrators, clinicians, biomedical engineers, procurement teams, and healthcare operations leaders. You will learn:

What an ECMO system is, what it does, and where it is typically used
When a facility might consider using it (and when it may not be suitable)
What you need before starting, including staffing, accessories, and pre-use checks
Basic operation concepts, key parameters, and how outputs are commonly interpreted
Safety practices, troubleshooting principles, and cleaning/infection control basics
A practical look at manufacturers, OEM considerations, distributors, and global market dynamics

Because ECMO programs often succeed or fail on logistics, not only clinical capability, you will also see recurring operational themes: staffing models, device uptime, consumable continuity, traceability, and post-event learning. These are the “hidden” requirements that determine whether an ECMO service line remains safe and sustainable.

Throughout, defer to your local regulations, facility protocols, and the manufacturer’s Instructions for Use (IFU), because device features and required procedures can vary by manufacturer.

What is Extracorporeal membrane oxygenation ECMO system and why do we use it?

Extracorporeal membrane oxygenation ECMO system is a form of extracorporeal life support (ECLS). It circulates a patient’s blood outside the body through a membrane oxygenator where oxygen is added and carbon dioxide is removed, then returns the blood to the patient. Depending on the configuration, it can provide respiratory support, circulatory support, or both.

It may help to view ECMO as a spectrum of extracorporeal support technologies rather than a single “mode.” Some systems are designed primarily for full cardiopulmonary support, while others focus on gas exchange with less emphasis on circulatory augmentation. There are also related approaches (for example, extracorporeal carbon dioxide removal) that may look similar from a device-handling standpoint but differ in target flow ranges, oxygenator design, and governance requirements. For procurement and biomedical engineering teams, this matters because “ECMO-like” devices can carry very different consumable requirements and staff competencies even when the bedside setup appears familiar.

Core purpose (in practical terms)

Respiratory support: partially or largely replaces lung gas exchange to “buy time” for recovery or decision-making.
Circulatory support: provides cardiac output assistance by returning blood to the arterial system (configuration-dependent).
Bridge function: can be used as a bridge to recovery, bridge to transplant, or bridge to another therapy pathway, based on clinical governance and capacity.

Operationally, ECMO can also serve as a “stabilization platform” that allows time for diagnostics, procedures, and inter-facility referral decisions when the patient cannot be safely supported by conventional ventilation and/or vasoactive strategies alone. In some programs, it is integrated into a broader escalation pathway that includes specialized imaging access, interventional services, and rapid consultation with transplant or advanced heart failure teams (where available).

Major components you will see in an ECMO setup

An Extracorporeal membrane oxygenation ECMO system is typically composed of:

Pump (commonly centrifugal in contemporary systems)
Membrane oxygenator (gas-exchange cartridge)
Tubing circuit (often heparin-bonded or biocompatibility-coated; varies by manufacturer)
Cannulas and connectors (patient access/return; single-use)
Console/driver with user interface, alarms, and power management
Sensors/monitors (flow, pressure, temperature, venous saturation; availability varies by manufacturer)
Sweep gas supply (oxygen/air blend) and gas control (integrated or external; varies by manufacturer)
Heat exchanger / temperature control (integrated or external; varies by manufacturer)

Many real-world ECMO carts include additional “supporting hardware” that is easy to overlook during purchasing but critical during emergencies and transport, such as:

Circuit clamps and line organizers (to prevent accidental kinks, tension, or misconnections)
Sampling ports and stopcocks (program-dependent; these influence infection control and hemolysis risk if mishandled)
Bubble detection and air management accessories (availability and sensitivity vary by system)
Transport frames, pole mounts, and securement straps (important for patient movement and to reduce vibration-related alarms)
Backup power modules and spare batteries (especially for mobile and transport-ready consoles)
Data ports, event logging modules, or network interfaces (important for documentation, QI review, and sometimes cybersecurity review)

From an operations standpoint, think of it as a tightly coupled system of capital equipment (console/pump driver, monitoring modules) plus high-cost disposable consumables (oxygenators, circuits, cannulas, connectors).

A practical procurement reminder: ECMO disposables are not interchangeable “generic plastics” in many ecosystems. Tubing pack revision changes, connector type differences, sensor compatibility, and oxygenator generation updates can all affect what you can safely connect to what. Hospitals that run multiple ECMO platforms should explicitly plan for this complexity and consider whether standardizing on fewer circuit families reduces training burden and stocking errors.

Common configurations (conceptual overview)

Facilities commonly discuss ECMO in terms of blood drainage and return locations:

Veno-venous (VV): blood drained from venous system and returned to venous system (primarily respiratory support).
Veno-arterial (VA): venous drainage with arterial return (respiratory + circulatory support).
Hybrid configurations: used in certain cases and programs (naming and approach vary by protocol).

Within those broad labels, programs may further distinguish between peripheral cannulation (often used in ICU or emergency pathways) and central cannulation (often associated with cardiac surgery pathways), as well as single-site dual-lumen approaches (commonly seen in some VV pathways). These details are not just clinical—cannulation strategy changes how lines are routed, how securement is performed, how transport is executed, and how certain alarms are interpreted.

The precise setup, cannulation approach, and monitoring expectations should be standardized in your ECMO program policies.

Common clinical settings where it appears

Extracorporeal membrane oxygenation ECMO system is most commonly found in:

Adult, pediatric, and neonatal ICUs (medical and surgical)
Cardiac ICUs and post-cardiotomy recovery areas
Operating rooms (as a rescue or planned adjunct in selected programs)
Emergency departments (in centers that provide ECPR pathways; program-dependent)
Transport (ground/air) with dedicated portable ECMO capability

Depending on program design, ECMO equipment may also need to interface with procedural areas that are not traditionally “ECMO-native,” such as CT suites, interventional radiology, or catheterization labs. This has practical implications for power outlets, gas availability, corridor clearance, elevator dimensions, and whether the transport frame can be safely secured during imaging or procedures. Facilities that anticipate frequent movement often standardize an “ECMO-ready” transport route and ensure staff can rapidly identify where backup oxygen cylinders and emergency power access points are located.

Key benefits (patient care and workflow)

Benefits depend on case selection and program maturity, but operationally ECMO can:

Provide time-sensitive organ support when conventional options are inadequate
Enable standardized high-acuity workflows (checklists, packs, emergency drills)
Concentrate expertise in specialized teams, improving consistency and readiness
Support complex transfers by maintaining oxygenation/perfusion during transport
Create a defined platform for quality monitoring (device logs, adverse event review)

In addition, many hospitals find that a mature ECMO service line drives broader improvements in high-reliability care practices, such as disciplined handovers, better line labeling standards, and more rigorous equipment acceptance testing. Some centers also use ECMO as a catalyst for simulation-based education that benefits other resuscitation and critical care pathways.

It also introduces substantial workflow burdens: continuous monitoring, high staff intensity, frequent lab dependencies, and a critical reliance on safe device handling.

When should I use Extracorporeal membrane oxygenation ECMO system (and when should I not)?

Decisions to initiate or withhold ECMO are clinical, ethical, and resource-based. This section provides general, non-patient-specific considerations to support program planning and governance—not medical advice.

A useful operational mindset is that ECMO initiation is rarely a single clinician’s decision; it is the activation of a service line. Many hospitals implement an “ECMO activation” process similar to trauma activation or cath lab activation, with a structured call tree, time-stamped checklist, and clear documentation expectations. This helps avoid late, rushed starts that increase risk to both patient and staff.

Appropriate use cases (program-level view)

Facilities with trained teams and clear protocols may consider Extracorporeal membrane oxygenation ECMO system for:

Severe respiratory failure that is potentially reversible and not responding to optimized conventional support
Refractory cardiogenic shock or severe cardiac failure where temporary support is part of an agreed pathway
Post-cardiotomy support in centers with cardiac surgery capability and predefined criteria
Bridge-to-decision or bridge-to-therapy pathways (for example, transplant evaluation in appropriate centers)
Resuscitation pathways (ECPR) in systems that can deliver rapid cannulation, ICU capacity, and post-arrest care (highly program-dependent)

Depending on local capability, some programs also plan ECMO support as part of:

High-risk procedural support (for example, as a standby for selected interventions) when the center has defined criteria, equipment readiness, and staffing availability
Bridge to durable mechanical circulatory support in institutions that provide ventricular assist device (VAD) therapy or have referral agreements

The key operational point: ECMO should be used within a structured ECMO service, not as an ad hoc “last resort” without staffing, supplies, and a realistic exit strategy.

When it may not be suitable (common non-clinical and program constraints)

Even when technically possible, ECMO may be unsuitable when:

There is no trained 24/7 team to manage circuit and patient monitoring
The facility cannot support rapid escalation (surgery, interventional procedures, imaging, blood bank, ICU staffing)
Power, gas supply, or equipment redundancy is unreliable (especially in transport scenarios)
The program cannot provide anticoagulation monitoring capability and bleeding management infrastructure consistent with local protocols
There is no plan for continuation of care, including weaning, transfer, or palliative pathways as appropriate to local governance

Additional common constraints that affect program feasibility include:

Limited blood bank bandwidth to support urgent component availability, massive transfusion pathways (if needed), and consistent product delivery to ICU/OR
No immediate access to procedural support (for example, vascular surgery or interventional radiology coverage) when complications require urgent intervention
Inadequate imaging logistics (difficulty obtaining timely bedside radiography/ultrasound or safe transport to CT) which can slow troubleshooting and increase time-to-correction
Space and ergonomics issues such as overcrowded ICU bays, poor line-of-sight to the circuit, or insufficient space to safely manage multiple infusion pumps and tubing runs

General safety cautions and contraindications (non-clinical framing)

Common reasons programs pause or avoid ECMO initiation include:

Uncontrolled environment: inadequate space, infection control limitations, or inability to safely position equipment
Supply chain fragility: uncertain availability of oxygenators/cannulas of required sizes, clamps/connectors, and compatible disposables
Inadequate service coverage: no biomedical engineering support for urgent checks, no loaner device plan, or unclear after-hours vendor escalation
Transport risk without capability: attempting transfer without trained transport ECMO team, spare circuit components, and backup power/gas
Governance gaps: absent consent processes, unclear documentation standards, or no morbidity/mortality review mechanism

Programs may also factor in device lifecycle risk. For example, if a console fleet is aging, if spare parts are scarce, or if disposables are frequently back-ordered, the operational risk rises even when clinical indications exist. Similarly, if an IFU update or a field safety notice changes how a component must be used, the program may temporarily pause starts until re-training and risk assessment are completed.

Operational ethics and capacity management

ECMO is resource-intensive. Programs should predefine:

Eligibility pathways aligned with local capabilities and bed availability
Surge plans (e.g., respiratory outbreak) that protect staff safety and device availability
Escalation criteria for referral to higher-level ECMO centers and back-transfer policies

Capacity planning also includes staff wellbeing and sustainability. ECMO coverage can be exhausting for specialist teams; without a realistic staffing plan (rotation design, rest periods, backup coverage, and psychological safety), performance can degrade over time. Mature programs often use scheduled debriefs, fatigue-aware rostering, and routine simulation refreshers to maintain high reliability.

In short: ECMO is not only a medical equipment decision—it is a whole-system commitment.

What do I need before starting?

A safe Extracorporeal membrane oxygenation ECMO system start depends on readiness across infrastructure, people, processes, and supplies.

A common operational pitfall is to focus only on the console purchase while underestimating the “wrap-around” requirements: tubing packs, cannulas across size ranges, clamps and connectors, heater-cooler integration, spare batteries, and trained staff who can respond at 2 a.m. Programs that succeed tend to build readiness as a repeatable package—often called an “ECMO cart” or “ECMO start pack”—that can be deployed quickly and consistently.

Required setup, environment, and accessories

At minimum, most programs plan for:

Space and access: adequate room around the bed for cannulation, line management, and emergency interventions
Reliable power: dedicated outlets, emergency power circuits, and battery verification for transport-capable consoles
Gas supply: oxygen/air sources for sweep gas and appropriate regulators (integrated blending varies by manufacturer)
Temperature management: heat exchanger and temperature controller as required (integrated or external; varies by manufacturer)
Monitoring: multi-parameter bedside monitor, invasive pressure capability as per local practice, and access to blood gas testing
Consumables: sterile circuit pack, oxygenator, pump head (if disposable), cannulas, securement devices, clamps, connectors, pressure/flow sensors where used
Emergency equipment: hand-crank/manual backup (if supported), spare clamps, spare connectors, and a plan for rapid circuit change-out per protocol
Blood and lab support: ability to support protocolized anticoagulation monitoring, hemolysis evaluation, and transfusion logistics (specifics vary by facility)

Many programs also add practical “readiness enhancers” that reduce delays and errors during high-stress starts:

Standardized cannulation kit layout (sterile drapes, dressings, sutures/securement, line labels) so every start looks and feels the same
Point-of-care ultrasound availability (for access guidance and troubleshooting), coordinated with local equipment policy
Spare oxygen cylinder strategy for transport and for pipeline interruption scenarios, with clearly defined minimum cylinder pressure thresholds
Environmental controls such as adequate lighting, uncluttered floor space, and a plan to manage multiple infusion pumps and ventilator tubing without crossing ECMO lines
Waste management readiness for rapid disposal of contaminated disposables and safe handling of blood-contaminated spills

For procurement teams, the accessory list should be mapped to a bill of materials with compatibility rules (console model ↔ oxygenator ↔ tubing pack ↔ sensors).

A further operational best practice is to maintain a “par level” for consumables: a minimum on-hand inventory that accounts for lead times, expiry, and surge scenarios. Because oxygenators and circuits can have finite shelf lives, inventory management should include expiry rotation, periodic cycle counts, and rapid recall-response capability.

Training and competency expectations

ECMO is not a “plug-and-play” clinical device. Programs commonly require:

Role-based training: cannulating clinicians, ECMO specialists, bedside nurses, perfusion/clinical engineering, transport teams
Competency validation: initial credentialing plus periodic revalidation (simulation is widely used)
Emergency drills: air-in-line response, pump failure, oxygen supply failure, massive bleeding response, transport failure scenarios
Human factors training: line tracing, standardized labeling, closed-loop communication, and handover structure

Many hospitals formalize training with a competency matrix that defines which tasks each role can perform independently (for example, adjusting sweep gas, changing alarms, troubleshooting sensor faults, or preparing a circuit). They may also track training completion by device model and software version, because alarm logic and screen layouts can change across revisions.

Training content and minimum case numbers vary by institution and region.

Pre-use checks and documentation (practical essentials)

Before initiating support, most facilities implement a standardized pre-use checklist covering:

Device readiness: preventive maintenance status, self-test results, software/firmware status (if applicable), battery health
Disposable verification: correct model, size, compatibility, integrity of sterile packaging, expiry date, and lot/serial traceability
Circuit preparation: priming procedure completed, de-airing confirmed, clamp positions verified, connectors secured
Alarm verification: audio/visual alarms, bubble detection (if present), pressure alarms (if present), and limits set per protocol
Gas verification: correct gas connection, oxygen analyzer verification if used, sweep gas availability and backup plan
Documentation: start time, initial settings, team members, equipment IDs, and a clear plan for monitoring frequency and escalation

Additional high-value checks often included in mature programs:

Recall/field notice verification for both the capital device and the disposables (especially if components have recently changed suppliers or revisions)
Heater unit readiness (water level, alarm test, temperature probe integrity) where external heater-cooler units are used
Physical inspection of the pump head latch, oxygenator housing, and sensor cables for cracks, wear, or damage that could cause leaks or false alarms
Labeling and line tracing readiness before patient connection—ensure the team can visually follow the drainage and return limbs from cannula to console without ambiguity

If a step is unclear, default to: Varies by manufacturer and consult the IFU.

How do I use it correctly (basic operation)?

Basic operation of an Extracorporeal membrane oxygenation ECMO system can be described as a controlled workflow: prepare equipment, establish the circuit, initiate flow, stabilize, then continuously monitor and adjust within protocol.

This is a high-level overview; follow your facility SOPs and manufacturer IFU.

1) Prepare the console and circuit (setup and priming)

Typical steps include:

Position the console/pump driver and ensure stable mounting (bedside pole, cart, or transport frame).
Connect to reliable power and confirm battery operation if transport is anticipated.
Assemble the disposable circuit (tubing, oxygenator, sensors) using sterile technique per protocol.
Prime the circuit and remove air using the facility’s approved method.
Confirm integrity of all connections, clamp placement, and secure routing of lines to reduce snagging.

Operational details that can meaningfully reduce risk during this phase include:

Ensure correct component orientation (oxygenator direction, heat exchanger connections, and any “inlet/outlet” marking), because reversed orientation can compromise performance and confuse troubleshooting.
De-airing discipline: microbubbles can persist even when gross air is removed, so many programs use a stepwise approach (slow filling, tapping/venting as allowed by the IFU, and visual confirmation at known air-trap points).
Line management early: route the circuit so that the drainage limb is not compressed by bed rails or equipment, and so that the return limb is not under tension (tension can worsen connector leaks over time).
Sensor placement verification: if using external flow probes or pressure transducers, confirm they are placed in the correct direction and location; reversed probes can produce misleading data.

Calibration/zeroing steps may apply for pressure transducers, flow probes, or gas analyzers—varies by manufacturer.

2) Connect sweep gas and temperature control

Most ECMO oxygenators require a controlled gas flow (“sweep”) across the membrane:

Verify gas source, blender (if used), and correct connection to the oxygenator gas inlet/outlet.
Set sweep gas parameters as ordered by the clinical team and within protocol.
If temperature control is used, connect and verify the heat exchanger circuit and temperature alarms.

Additional practical considerations include:

Backup gas readiness: in some settings, a secondary cylinder is staged with a regulator already attached, so a supply switch can occur rapidly without searching for parts.
Oxygen analyzer use: if your workflow includes verifying oxygen concentration, ensure the analyzer is calibrated and that staff understand where and how to sample gas safely.
Exhaust awareness: the oxygenator gas outlet exhaust should not be obstructed; some programs also consider exhaust filtration or routing practices depending on local infection control policy and environmental risk assessment.
Condensation management: depending on room temperature and gas flow, condensation can appear in gas lines; staff should know what is normal vs what indicates a connection issue.

Key concept: blood flow primarily affects oxygen delivery, while sweep gas flow is a major lever for CO₂ removal. The exact relationships depend on patient condition, configuration, and device design.

3) Initiate ECMO support (team-based and protocol-driven)

Initiation includes clinical steps (e.g., cannulation) performed by trained clinicians. From a device-handling standpoint:

Confirm correct identification of drainage vs return lines using standardized labels and line tracing.
Use a two-person verification before unclamping any patient-connected line.
Start the pump at low speed and increase gradually per protocol while monitoring for air, abnormal pressures, or instability.
Confirm circuit flows, pressures, and oxygenator function using the console displays and independent clinical monitoring.

Many ECMO teams also perform a formal “time-out” immediately before initiating flow, similar to surgical time-outs, to confirm:

Correct patient identity and consent/documentation status per policy
Configuration (VV/VA/hybrid) and intended clinical goals
Cannula types/sizes and securement plan
Emergency plan roles (who clamps, who manages airway/ventilator, who calls for additional support)

This reduces the likelihood of rushed, uncoordinated actions during the highest-risk minutes of a start.

4) Routine operation and monitoring (what teams commonly watch)

A typical operating loop includes:

Circuit parameters: pump speed, blood flow, pressures (if measured), temperature, venous saturation (if measured), and alarms.
Oxygenator performance indicators: changes in pressure drop, gas exchange effectiveness (often assessed with blood gases), and visible clot burden (where observable).
Patient monitoring: vital signs, oxygenation indicators, perfusion markers, and laboratory trends per protocol.

Many programs define a routine “ECMO circuit check” at set intervals (for example, hourly) that includes:

Visual inspection of tubing for kinks, color change, or new fibrin/clot appearance
Verification that clamps are where they should be (and that emergency clamps are immediately available)
Check of securement points and dressings around cannulas to prevent accidental movement
Review of alarm history since the last check and confirmation that alarm limits remain appropriate to the current phase of care

Documentation often emphasizes trends rather than single values. Many consoles record events and alarms; ensure your team knows how to export or review logs (capabilities vary by manufacturer).

5) Typical settings and what they generally mean (non-prescriptive)

Common adjustable parameters include:

Blood flow rate: the amount of blood circulated through the circuit (commonly displayed in L/min).
Pump speed: rotation speed (often RPM) used to generate flow, influenced by cannula size/position and patient resistance.
Sweep gas flow rate: gas flow across the oxygenator membrane, affecting CO₂ removal dynamics.
Delivered oxygen fraction to the oxygenator (FdO₂): oxygen concentration in sweep gas, affecting oxygenation across the membrane.
Temperature setpoint: target blood temperature leaving the heat exchanger (if used).

Some consoles also display additional derived indicators such as pump power/torque, inlet pressure trends, or estimated flow when a direct flow sensor is not present. These can be useful operationally because sudden changes may indicate mechanical problems (for example, drainage insufficiency, kinking, or rising resistance across the oxygenator). However, derived numbers can vary by system design and should be interpreted in the context of the manufacturer’s technical guidance.

Target values are clinical decisions and vary widely by program and patient.

6) Transport, handover, and continuity of care

If the ECMO patient is transported:

Confirm battery time, spare oxygen supply, and physical securement of the console and circuit.
Use standardized handover content: configuration, cannula sites, current settings, recent alarms, and contingency plans.
Maintain line visibility and prevent kinks during movement.

Transport planning also benefits from a “what would break first?” assessment:

Is the limiting factor battery runtime, oxygen cylinder volume, or staff fatigue?
Do you have a spare oxygenator/circuit components available if a connector leaks mid-transport?
Is the transport route clear of MRI zones, narrow doorways, or elevators that cannot accommodate the bed plus ECMO frame?

Continuity of care improves when the receiving unit is pre-briefed on the ECMO configuration, current device model/software version, and any quirks (for example, known sensor intermittency). A structured handover reduces the chance that a new team misinterprets an alarm or changes a setting without understanding recent events.

7) Discontinuation and post-use handling (general)

Stopping ECMO and decannulation are clinical decisions. Operationally:

Ensure a controlled shutdown sequence per IFU and protocol.
Treat circuit disposables as biohazard waste.
Clean and disinfect reusable components before return to service.

Post-use handling can also include:

Device data management: download or review console logs if your program uses them for QI, incident review, or documentation support.
Restocking and readiness reset: ensure the ECMO cart is returned to a ready state with replacement disposables, clamps, and batteries so the next activation is not delayed.
Post-case debrief: many teams perform a short debrief focusing on what went well, what nearly went wrong, and what supplies were unexpectedly missing—this supports continuous improvement.

How do I keep the patient safe?

Extracorporeal membrane oxygenation ECMO system introduces risks that are mechanical, biological, and human-factor driven. Patient safety depends on disciplined processes more than any single feature.

From a program design view, it helps to categorize risk into: (1) circuit integrity failures (air, rupture, disconnection), (2) performance failures (inadequate gas exchange, rising resistance), (3) monitoring failures (missed alarms, misread sensors), and (4) process failures (handover gaps, documentation gaps, training drift). Effective safety systems address all four categories rather than focusing only on device alarms.

Safety practices and monitoring (program fundamentals)

High-reliability ECMO programs commonly implement:

Standardized checklists: start, shift-change, transport, and emergency checklists
Redundancy: backup power plan, backup oxygen supply, spare circuit components per protocol
Continuous surveillance: defined monitoring frequencies, clear escalation triggers, and clear role assignments
Circuit integrity focus: secure connections, stable routing, and visible line tracing to reduce misconnections

Monitoring often spans:

Circuit flows/pressures (where available)
Signs of oxygenator performance change (trend-based)
Anticoagulation monitoring per protocol (method and targets vary by facility)
Patient perfusion and oxygenation trends using bedside monitoring and lab testing

Programs commonly define explicit “stop and reassess” triggers (for example, repeated unexplained low-flow events, abnormal pressure trends, or repeated air alarms). The point is not to create more alarms; it is to reduce normalization of deviance—where staff get used to a device behaving “a little wrong” until a major event occurs.

Alarm handling and human factors

Alarm systems are critical but can be undermined by alarm fatigue. Practical approaches include:

Define who responds first and who supports (e.g., bedside nurse vs ECMO specialist).
Never silence and walk away: alarms should trigger immediate assessment of patient and circuit.
Use structured troubleshooting: confirm clamps/lines, pump function, gas supply, and sensor integrity before changing settings.
Log alarms/events: consistent documentation supports quality improvement and incident review.

Alarm discipline is strengthened when teams routinely review alarm limits and ensure they match the current clinical phase (initiation, stable support, transport, weaning). Overly tight limits create constant noise; overly loose limits delay detection. Many institutions set “default limit templates” per configuration and then allow protocolized adjustments with documentation.

Human-factor safeguards that reduce serious errors:

Standard labels for drainage/return lines
Two-person verification for clamp changes and line access
“Trace the line” practice before any connection/disconnection
Clear shift handover that includes recent instability and near-misses

Some teams also standardize verbal callouts during critical steps (for example, “Drainage unclamped,” “Return unclamped,” “Pump start,” “Sweep on”), which can reduce miscommunication in noisy ICUs.

Emphasize protocols and manufacturer guidance

Safety depends on two documents that should never conflict:

Your facility ECMO policy/SOP (roles, thresholds, escalation, documentation)
The manufacturer IFU (device-specific limits, compatibility, cleaning agents, and alarm meanings)

If your SOP deviates from IFU, ensure there is a documented risk assessment and governance approval.

Environmental and equipment safety

Because ECMO is complex hospital equipment, include:

Electrical safety checks and preventive maintenance for consoles and heater units
Gas safety: correct regulators, secure cylinders, and awareness of oxygen fire risk
Physical safety: secure carts/poles, avoid trip hazards, and protect tubing from compression

Facilities should also consider practical compatibility issues, such as where the console can safely be positioned relative to bed movement, whether power cords create trip hazards during emergent procedures, and whether the device is suitable for the intended environment (for example, transport vibration, elevator thresholds, or limited space in imaging suites). Even small environmental changes—like moving the bed, raising rails, or repositioning a ventilator—can unintentionally compress a drainage line, so routine line checks after room rearrangements are a simple but high-impact safety habit.

How do I interpret the output?

Outputs from an Extracorporeal membrane oxygenation ECMO system vary by model, but most consoles provide a mix of real-time parameters, alarm states, and trend data. Interpretation should always be correlated with clinical assessment and laboratory testing, per protocol.

A key operational point is that some “outputs” are directly measured (for example, a calibrated flow sensor), while others are estimated (for example, calculated flow based on pump speed and assumed resistance). Teams should know which is which on their specific platform, because an estimated number may look stable even when a sensor-driven number would show deterioration.

Types of outputs/readings you may see

Common console or accessory readings include:

Blood flow (calculated or measured)
Pump speed (RPM) and sometimes pump power/torque indicators
Pressures (pre- and post-oxygenator, venous/arterial line pressures) if pressure monitoring is integrated
Pressure drop across the oxygenator (delta pressure), where available
Blood temperature (inlet/outlet) if temperature probes are used
Venous oxygen saturation or similar measurements if equipped (sensor availability varies)
Gas settings (sweep flow and FdO₂ setpoints) if integrated
Alarm codes/messages including air detection, occlusion/high pressure, low flow, sensor fault, or power status

Some systems also provide:

Trend graphs over hours/days for flow and pressure
Event logs with timestamps for alarms and setting changes
Battery runtime estimates and power-source history
Service reminders tied to preventive maintenance intervals

These features can be valuable for governance reviews (for example, to reconstruct what happened during a low-flow event) and for training (reviewing alarm sequences with new staff).

How clinicians typically interpret them (general patterns)

Trends matter: gradual changes can signal evolving problems (e.g., rising pressure drop may indicate oxygenator issues).
Cross-checking is standard: console readings are usually interpreted alongside bedside monitors and blood gases.
Configuration matters: the same number can mean different things in VV vs VA support, or with different cannulation strategies.

Operationally, teams often look for internal consistency: if pump speed increases but flow does not, something in the system may be limiting flow (for example, drainage limitation, kink, obstruction, or cannula position). If delta pressure rises without a corresponding clinical explanation, it can indicate increasing resistance across the oxygenator or tubing. If the console shows stable flow but the patient shows worsening perfusion markers, that discrepancy triggers a broader assessment of patient physiology and circuit function together.

Common pitfalls and limitations

Sensor drift or miscalibration: pressure and flow sensors may require setup steps; errors can mislead response.
Recirculation and mixing effects: measured oxygenation may not reflect systemic delivery in some configurations.
Overreliance on single indicators: a “normal” console value does not guarantee adequate patient support.
Device-to-device differences: display names, alarm logic, and parameter availability vary by manufacturer.

Other practical limitations include:

Intermittent signal dropouts from loose cables or fluid ingress into connectors (a common issue if cleaning is too wet).
False high-pressure alarms caused by transducer leveling errors or occluded pressure lines (where external transducers are used).
Flow measurement inaccuracies at extreme hematocrit/temperature ranges (system-dependent) or when probes are positioned incorrectly.

A practical rule for teams: if the patient condition and device numbers do not match, treat it as a safety event until reconciled.

What if something goes wrong?

When ECMO problems occur, the highest risk comes from delayed recognition, incorrect troubleshooting sequence, or loss of circuit integrity. Use a calm, scripted response and escalate early.

Many programs teach troubleshooting as two parallel workstreams: one clinician focuses on the patient (vitals, airway/ventilator, perfusion), while an ECMO specialist or perfusionist focuses on the circuit (lines, pump, oxygenator, gas). This division prevents “tunnel vision” and ensures a circuit issue is not mistaken for a purely patient-driven change (or vice versa).

A practical first-response mindset

Patient first: assess patient status and bedside monitor trends while another team member assesses the circuit.
Call for help early: predefined escalation (ECMO specialist, intensivist, perfusion, surgeon, biomedical engineering).
Do not improvise connections: avoid non-standard tubing/connector substitutions unless explicitly approved in protocol.

A helpful operational discipline is to use “closed-loop” verbalization during urgent steps: one person announces an action (e.g., “Clamping drainage”), another person repeats it, and the first confirms completion. This reduces inadvertent clamp errors and supports shared situational awareness.

Troubleshooting checklist (general, non-brand-specific)

Use a structured approach:

Confirm power status, battery indicator, and that the pump is actually running.
Check for kinks, compression, or accidental clamping on drainage/return lines.
Verify all connectors are seated and secured; look for leaks or wet connectors.
Inspect for visible air, froth, or unusual vibration/noise.
Confirm sweep gas source, correct connection, and adequate supply pressure.
Review alarms in order of priority; do not ignore repeating alarms.
Cross-check suspicious values with independent measurements (e.g., blood gas, bedside saturation).

Many teams also add “look, listen, feel” cues during this checklist:

Look for chattering of the drainage line (may indicate inadequate drainage or suction events)
Listen for new pump sounds (bearing noise, vibration, or alarm tone changes)
Feel for unexpected warmth on the pump housing or heater connections (equipment fault consideration)

Common scenarios and what to consider

Low-flow alarms: may relate to cannula position, obstruction, hypovolemia, kinked tubing, pump issues, or sensor error (varies by setup).
High-pressure/occlusion alarms: consider tubing compression, clot burden, kinked return line, or oxygenator resistance change.
Inadequate gas exchange: verify sweep gas delivery, oxygen source, oxygenator integrity, and confirm with blood gas testing.
Air alarm: treat as urgent; follow facility emergency algorithm for air management and circuit safety.
Power failure: switch to emergency power/battery plan; ensure transport backup procedures are known and rehearsed.

Other operationally important scenarios include:

Sudden rise in oxygenator delta pressure (if measured): can indicate increased resistance; programs should have a clear escalation and “circuit change-out readiness” plan (who primes, what equipment is needed, where spares are stored).
Sweep gas disconnection or depleted cylinder: often presents as deteriorating CO₂ removal; a simple “gas line check” step in routine rounding can prevent this.
Heater/cooler malfunction: may trigger temperature alarms or device faults; staff should know whether the ECMO console can operate safely without active temperature control and what the backup plan is (varies by program and patient needs).
Sensor failure: loss of pressure or flow readings can lead to risky decisions; teams should know how to safely operate temporarily with alternative monitoring or whether the sensor must be replaced immediately per protocol.

When to stop use (general guidance)

Stopping ECMO is a clinical decision, but there are device-related situations where teams may need to pause, clamp, or transition per emergency protocol, such as:

Uncontrolled air entry into the circuit
Critical pump failure without immediate backup
Major circuit rupture/leak or inability to maintain sterile integrity
Repeated device malfunction not resolvable by protocolized steps

Your SOP should explicitly define who can authorize stopping support and how to manage rapid circuit exchange.

From an operational readiness standpoint, programs that plan for “rare but catastrophic” events often keep a contingency kit available (spare pump head if applicable, spare oxygenator/circuit, emergency clamps, and a clear priming plan). They also define who has authority to open additional disposable packs after hours, because delays can occur when supplies are locked or stored far from the ICU.

When to escalate to biomedical engineering or the manufacturer

Escalate when:

Alarms persist despite correct setup and protocol troubleshooting
There are repeated sensor faults, unexpected shutdowns, or software errors
Hardware damage is suspected (cracks, connector failures, abnormal pump head wear)
Preventive maintenance status is uncertain or overdue
You need device log extraction or manufacturer-level technical interpretation

Always preserve traceability: record serial numbers, disposable lot numbers, and event timelines.

In many hospitals, biomedical engineering also plays a key role after any significant event by (1) quarantining the device if needed, (2) downloading logs, (3) documenting the inspection, and (4) coordinating with risk management and the vendor for any formal investigation.

Infection control and cleaning of Extracorporeal membrane oxygenation ECMO system

Extracorporeal membrane oxygenation ECMO system combines sterile single-use blood-contacting components with reusable consoles and accessories. Infection control requires clear separation of what is disposed, what is disinfected, and what is maintained.

Because ECMO equipment often moves between rooms and units (ICU, OR, ED, imaging, transport corridors), it can become a “high-touch mobile surface.” Many programs address this by assigning specific consoles to isolation rooms when feasible, using disposable covers for select surfaces (where permitted), and implementing a documented terminal cleaning process after each patient episode.

Cleaning principles (what is typical)

Single-use disposables: oxygenator, tubing circuit, and cannulas are typically sterile and single-use; reprocessing is generally not intended unless explicitly permitted by local regulation and manufacturer (often not).
Reusable components: console surfaces, touchscreens, holders, and external sensor cables are cleaned and disinfected per IFU.

Disinfection vs. sterilization (general clarity)

Cleaning: removal of visible soil and organic material.
Disinfection: reduces microorganisms on surfaces; requires correct agent and contact time.
Sterilization: eliminates all microbial life; usually applied to instruments designed for sterilization, not to ECMO consoles.

Follow your infection prevention team’s approved product list and the device IFU to avoid material damage.

A practical point for biomedical engineering: aggressive disinfectants or excessive wetting can degrade plastics, cloud screens, peel labels, or cause button sticking. Damage to labels and controls becomes a safety issue, not merely a cosmetic one, because it can obscure alarm meanings or connector identification.

High-touch points to prioritize

Commonly missed areas:

Touchscreen and control knobs/buttons
Handles, cart rails, pole clamps, and cable strain-relief points
Pump head exterior housing and latch areas
Gas connection ports and flowmeter/blender knobs (if external)
Alarm speakers/grilles (avoid fluid ingress)
Power cords and network/data ports

Also consider:

Undersides of handles and rails where hands naturally grip
Velcro straps or reusable securement bands on transport frames (these can harbor contaminants if not cleaned properly)
Areas behind cable bundles where dust and residue can accumulate

Example cleaning workflow (non-brand-specific)

Don appropriate PPE and treat surfaces as contaminated.
Remove gross contamination using approved wipes/detergent method.
Apply hospital-grade disinfectant compatible with device materials; respect contact time.
Allow surfaces to dry; do not soak or spray directly into vents/ports.
Inspect for cracks, peeling labels, or sticky controls that may impair safe operation.
Document cleaning and return-to-service status per local policy.

Facilities that manage high-consequence pathogens often add an extra step: a documented “release from isolation” process, where infection prevention confirms the device is safe to return to general circulation. Whether this is needed depends on local policy and the pathogens involved.

Medical Device Companies & OEMs

Understanding the manufacturer ecosystem helps procurement and engineering teams manage quality, serviceability, and lifecycle risk for an Extracorporeal membrane oxygenation ECMO system program.

Because ECMO relies on both capital equipment and single-use components, vendor selection often includes two parallel evaluations: (1) how reliable and serviceable the console is, and (2) how stable and scalable the disposable supply chain is. A technically excellent console becomes operationally unsafe if oxygenators or circuits are frequently unavailable, substituted without training, or delivered with inconsistent revisions.

Manufacturer vs. OEM (Original Equipment Manufacturer)

A manufacturer markets the finished medical device under its name and is responsible for regulatory compliance, post-market surveillance, and IFU content.
An OEM produces components or subsystems that may be incorporated into the final product (e.g., pumps, sensors, oxygenator cartridges, electronics), sometimes under private label arrangements.

In ECMO, OEM relationships can exist across tubing sets, coatings, sensors, and sometimes even complete modules—details are often not publicly stated.

How OEM relationships impact quality, support, and service

Serviceability: parts availability and repair pathways can depend on OEM supply continuity.
Training: field service engineers may be trained on OEM modules differently than on the full system.
Change control: component substitutions can occur over time; hospitals should request documentation of compatibility and revision history during procurement.
Accountability: for safety events, the legal manufacturer remains responsible, but investigation may involve OEM technical input.

Hospitals can reduce risk by asking structured questions during procurement and periodic reviews, such as:

How are disposable revisions communicated to customers, and what retraining is required?
What is the expected service life of the console and key modules (battery packs, screens, pump drivers)?
Are there validated alternative consumables or only single-source options?
What is the process for urgent replacement of a failed console (loaner availability, response time, after-hours support)?

Top 5 World Best Medical Device Companies / Manufacturers

The following are example industry leaders commonly recognized in global medtech; inclusion is not a verified ranking and does not imply specific ECMO product availability in every country.

Getinge
Widely known for critical care and cardiovascular hospital equipment, including perfusion and intensive care technologies. The company has a broad global presence and typically supports complex capital equipment with service programs. Specific ECMO configurations, accessories, and availability vary by manufacturer and region.
Medtronic
A large multinational medical device company with extensive cardiovascular and critical care portfolios. It is generally recognized for large-scale manufacturing, clinical training infrastructure, and global distribution reach. ECMO-related offerings and support models can vary by country and subsidiary structure.
Terumo
A Japan-headquartered medtech company with strong presence in cardiovascular, perfusion, and blood management categories. Terumo products are widely used across hospitals globally, with regional differences in product lines and regulatory clearances. ECMO system components and consumables availability vary by manufacturer and market.
LivaNova
Known for cardiac surgery and cardiopulmonary support categories in many regions. The company operates internationally, with product portfolios that can differ by geography and regulatory status. ECMO-related equipment and disposables should be confirmed directly with local representatives, as availability varies by manufacturer.
Fresenius Medical Care
Globally recognized for dialysis services and related medical equipment, with a substantial footprint in chronic care infrastructure. In some regions, the company is also associated with extracorporeal therapies beyond dialysis through acquisitions and subsidiaries, though specifics vary by manufacturer and market. Buyers should validate local service capability for ICU-based extracorporeal support devices.

Vendors, Suppliers, and Distributors

For ECMO programs, understanding who sells, delivers, and supports the device is as important as selecting the clinical device itself.

A frequent operational lesson is that “availability on paper” is not the same as “availability at 3 a.m.” ECMO programs often require urgent shipment of disposables, rapid swap of a faulty console, and reliable stocking of multiple cannula sizes. Contracts and distributor capabilities should be evaluated against these realities, not just standard procurement lead times.

Role differences: vendor vs. supplier vs. distributor

Vendor: a commercial entity that sells products to the hospital; may be the manufacturer, an authorized reseller, or a tender partner.
Supplier: provides goods (often consumables) and may manage recurring inventory, forecasting, and order fulfillment.
Distributor: purchases from manufacturers and resells to hospitals, sometimes providing warehousing, local regulatory support, and first-line service coordination.

In ECMO, capital equipment is often sold direct by manufacturers in many countries, while consumables and accessories may involve distributors—this varies by market structure.

Operationally, hospitals often prefer authorized distribution channels for ECMO disposables to reduce the risk of counterfeit, improper storage, or undocumented product revisions. Where grey-market sourcing exists during shortages, programs should involve risk management and clinical governance because traceability and IFU alignment can be compromised.

Top 5 World Best Vendors / Suppliers / Distributors

The following are example global distributors (not a verified ranking). Their ability to support ECMO-related hospital equipment depends on country, contracts, and authorizations.

McKesson
A major healthcare supply chain organization with large-scale logistics capabilities in select markets. Typically supports hospitals with procurement, inventory management, and broad product catalogs. ECMO capital equipment is often handled directly by manufacturers, but distributors may support associated consumables and hospital supplies depending on region.
Cardinal Health
Known for distributing medical products and supporting hospital supply chain operations in multiple markets. Often provides logistics, inventory programs, and procurement services. Availability of ECMO-specific items varies by manufacturer authorization and country footprint.
Owens & Minor
Recognized for supply chain services and distribution of medical supplies and consumables, with a focus on hospital operational continuity. Service offerings can include warehousing, delivery reliability, and sourcing support during shortages. ECMO program managers should confirm whether ECMO disposables are within the authorized portfolio.
DKSH
Provides market expansion and distribution services across multiple regions, especially in parts of Asia. Often supports regulatory, marketing, logistics, and after-sales coordination for healthcare manufacturers entering new markets. ECMO-related distribution, where present, is typically tied to specific manufacturer contracts.
Zuellig Pharma
A well-known healthcare services provider in parts of Asia with distribution and commercialization support. Commonly works with manufacturers to provide localized supply chain, cold chain (where required), and hospital engagement services. ECMO program coverage varies by country and manufacturer partnership.

Global Market Snapshot by Country

Below is a practical, qualitative snapshot of the Extracorporeal membrane oxygenation ECMO system market and related services. Availability, regulation, and service capability can vary widely within each country.

India
Demand is concentrated in tertiary private and large public hospitals, often linked to cardiac surgery and advanced ICU programs. Import dependence for consoles and disposables is common, and service quality varies by city and distributor coverage. Many programs also face challenges in maintaining consistent consumable availability across multiple sizes, and training pipelines can be uneven between metropolitan and smaller regional centers.

China
Large urban centers drive ECMO adoption, supported by major hospital investment and expanding critical care capacity. Domestic manufacturing is growing in some medical equipment categories, but many ECMO components and disposables may still be imported or reliant on international supply chains. Hospital systems may emphasize rapid scaling, which makes standardized training, device standardization, and distributor responsiveness particularly important.

United States
A mature ECMO ecosystem exists in many academic and large community systems, with established training pathways and reimbursement considerations. Competition focuses on device features, service contracts, and disposable supply reliability, with strong expectations for 24/7 technical support. Programs often emphasize data capture and quality review, including robust incident reporting and multidisciplinary governance.

Indonesia
ECMO access is largely urban and centered in referral hospitals, with limited nationwide coverage. Import logistics, training availability, and ongoing disposable supply are common constraints for program expansion. Geography across islands can make transport planning and stock positioning (buffer inventory) critical to avoid delays during urgent starts.

Pakistan
Programs are typically concentrated in large metropolitan tertiary centers, with significant reliance on imported devices and consumables. Scaling beyond major cities can be limited by ICU staffing, blood bank capacity, and service infrastructure. Where ECMO exists, maintaining a stable consumable pipeline and trained specialist coverage is often as challenging as acquiring the initial console.

Nigeria
ECMO availability is limited and highly concentrated, often constrained by funding, critical care workforce shortages, and supply chain complexity. Where programs exist, maintaining disposables, gas/power reliability, and service responsiveness are key operational challenges. Some centers explore partnership models and phased program development to build sustainable capability over time.

Brazil
Demand is driven by large private networks and major public referral centers, with regional disparities between major cities and remote areas. Import processes and local service coverage influence total cost of ownership and uptime. Larger systems may focus on vendor-managed inventory and regional warehousing to reduce delays in critical disposables.

Bangladesh
ECMO capacity is developing, typically in a small number of advanced hospitals in major cities. Reliance on imported medical equipment and the need for structured training programs are common barriers to broader adoption. Program growth often depends on predictable supply chains and the ability to retain trained staff in high-acuity roles.

Russia
Adoption is often concentrated in major urban medical centers with advanced surgical and ICU services. Sanctions, import restrictions, and supply chain variability can influence device availability, parts supply, and long-term service planning. Hospitals may place added emphasis on local technical capability, device redundancy, and long-horizon consumable procurement planning.

Mexico
Major metropolitan hospitals and private groups are key adopters, with growing interest in advanced critical care technologies. Import reliance and uneven service coverage outside large cities can affect program consistency and expansion. Training access and regional service response times are often key differentiators between vendors.

Ethiopia
ECMO access is limited and largely constrained by intensive care capacity, specialized staffing, and high cost of disposables. Where interest exists, partnership models, training pipelines, and reliable supply chains are central to feasibility. Programs considering ECMO often need parallel investment in lab capability, blood bank processes, and biomedical engineering support.

Japan
A highly developed critical care and perfusion environment supports advanced extracorporeal therapies in many centers. Expectations for device quality, regulatory compliance, and structured training are typically high, with strong manufacturer presence. Operational emphasis may include meticulous documentation, preventive maintenance discipline, and standardized competency frameworks.

Philippines
ECMO availability is centered in tertiary hospitals in major urban areas, with ongoing growth tied to private sector investment. Import dependence and the need for stable consumable supply and training remain key operational concerns. Programs may also need robust referral coordination given geographic dispersion and variable access outside major cities.

Egypt
Adoption is expanding in major public and private tertiary hospitals, often driven by complex cardiac and respiratory care needs. Variability in procurement processes and distributor service capability can influence program reliability. Many centers focus on strengthening training and ensuring rapid access to disposables to maintain readiness for emergent starts.

Democratic Republic of the Congo
ECMO access is very limited due to infrastructure constraints, critical care capacity, and high cost. When considered, programs often depend on external partnerships, centralized urban deployment, and robust supply planning. Power stability, gas availability, and maintenance logistics can be decisive feasibility factors.

Vietnam
Growing tertiary care capacity in major cities supports increasing ECMO capability, often tied to respiratory critical care and cardiac programs. Import reliance remains common, and service ecosystems are strongest in urban referral hospitals. Ongoing program maturation often centers on structured training, standardized documentation, and reliable consumable forecasting.

Iran
ECMO programs exist in advanced centers, but supply chain and import constraints can affect availability of disposables and replacement parts. Local engineering capability and hospital self-reliance can play a larger role in sustaining uptime. Programs may prioritize device platforms with robust serviceability and the ability to maintain a buffer inventory of critical consumables.

Turkey
A mix of public and private tertiary hospitals supports ECMO growth, with strong urban concentration. Procurement often evaluates both device performance and vendor service responsiveness, particularly for disposables and emergency replacements. Centers may focus on transport readiness and regional referral networks to ensure timely access for patients outside major cities.

Germany
A mature ICU and cardiac surgery landscape supports wide ECMO availability, with strong emphasis on standards, documentation, and quality systems. Market dynamics often focus on integration, training, and reliable service agreements. Many institutions also prioritize structured incident review processes and continuous competency validation for all ECMO roles.

Thailand
ECMO capacity is strongest in Bangkok and major referral hospitals, with expansion tied to critical care investment and clinician training. Import dependence for many systems and consumables means supply continuity planning is essential. Programs often emphasize standardized emergency drills and transport protocols to support safe inter-facility movement.

Key Takeaways and Practical Checklist for Extracorporeal membrane oxygenation ECMO system

Treat ECMO as a full service line, not just a device purchase.
Confirm 24/7 staffing model before expanding ECMO capacity.
Standardize configurations and naming to prevent line misconnections.
Use a two-person check for any clamp or connection change.
Maintain a documented bill of materials with compatibility rules.
Verify preventive maintenance status before every planned initiation.
Keep a contingency plan for power loss and battery depletion.
Secure backup sweep gas supply for transport and emergencies.
Document disposable lot numbers for traceability and recalls.
Train teams with simulation for air, pump, and gas failures.
Define clear escalation pathways and on-call responsibilities.
Build alarm response scripts and rehearse them regularly.
Avoid alarm fatigue by setting and reviewing limits carefully.
Trend oxygenator performance indicators, not single-point values.
Cross-check console readings with independent clinical measurements.
Keep tubing routed to minimize kinks, tension, and trip hazards.
Label drainage and return lines with standardized color coding.
Keep high-touch surfaces disinfected between patient encounters.
Use only IFU-approved disinfectants to prevent material damage.
Treat all blood-contact disposables as single-use unless authorized.
Ensure blood gas testing access supports your monitoring protocol.
Align anticoagulation monitoring capability with program expectations.
Predefine criteria for circuit change-out readiness and supplies.
Stock critical spare items: clamps, connectors, sensors, fuses.
Plan vendor support hours, response times, and loaner availability.
Require initial and ongoing competency validation for all roles.
Include biomedical engineering in device selection and acceptance testing.
Review device logs and adverse events in a governance forum.
Validate transport frames, securement, and oxygen cylinder management.
Include cybersecurity and data export needs in procurement requirements.
Confirm warranty terms and service contract coverage in writing.
Ensure training materials match the exact model and software version.
Build surge plans for outbreaks that increase respiratory support demand.
Centralize ECMO starts to experienced teams when feasible.
Audit documentation quality at shift change and after transport.
Coordinate with blood bank for rapid product availability processes.
Keep manufacturer IFU accessible at point of care at all times.
Implement strict handover templates for ICU-to-ICU transfers.
Define decontamination steps for console, cart, and accessories.
Quarantine devices after unexplained faults pending engineering review.
Record and report near-misses to improve system reliability.
Maintain a standardized ECMO cart layout so items are always in the same place.
Create a recall-response playbook (who checks lots, who quarantines stock, who notifies teams).
Validate oxygen analyzer and blender performance on a scheduled cadence per policy.
Plan “ECMO-ready” transport routes and practice them during drills (elevators, doorways, power access).
Use structured post-start and post-transport debriefs to capture workflow gaps while memory is fresh.
Confirm storage conditions and expiry rotation processes for oxygenators, circuits, and cannulas.
Define clear rules for after-hours access to locked ECMO disposables and emergency inventory.
Establish a fatigue-aware staffing plan for prolonged runs and surge periods.

If you are looking for contributions and suggestion for this content please drop an email to contact@surgeryplanet.com